Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs Lisata Therapeutics
Over the past year CLRB returned −62.5% and LSTA returned −61.9%; their daily moves had a correlation of 0.06.
CLRB −62.5% LSTA −61.9%Growth of $1, one year, split-adjusted
| Metric | CLRB | LSTA |
|---|---|---|
| Price | $1.24 | $1.06 |
| Market cap | $11.7M | $11.5M |
| Today | +2.48% | +3.92% |
| 1 month | −31.9% | −27.9% |
| 6 months | −51.6% | −67.1% |
| Year to date | −58.0% | −43.0% |
| 1 year | −65.5% | −62.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 114.5× |
| Net cash | $34.0M | $10.4M |
| Dividend yield | — | — |
| Volatility (60d) | 66.3% | 116.7% |
| Short % of float | 2.9% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).